HIGHLIGHTS
- who: GMJ et al. from the of Neurosurgery, Tehran University of Medical Sciences, Tehran, Iran have published the research work: Effects of Dimethyl Fumarate on the Karnofsky Performance Status and Serum S100u03b2 Level in Newly Glioblastoma Patients: A Randomized, Phase-II, Placebo, Triple Blinded, Controlled Trial, in the Journal: (JOURNAL)
- what: In this phase-II clinical trial, the authors aimed to evaluate and compare the efficacy of DMF comparison with SoC in individuals suffering from GBM. All patients were informed verbally as well as in writing with a pre-designed consent form including possible complications . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.